Is this your podcast?
Sign up
to track ranks and reviews from Spotify, Apple Podcasts and more
Dave Knapp Man On The Mounjaro
On The Pen: The Weekly Dose
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Listen now
Ratings & Reviews
☆
☆
☆
☆
☆
5.0 stars from 164 ratings
Very Informative
☆
☆
☆
☆
☆
“Great podcast that’s a very informative and current on the trends related to GLP-1 drugs.”
Faithchick2000 via Apple Podcasts ·
United States of America ·
11/06/24
Dave the man with the plan!
☆
☆
☆
☆
☆
“Dave always keeps GLP-1 patients well informed in the politics & procedures of drug manufacturers. Love his work!”
tatiFluke via Apple Podcasts ·
United States of America ·
10/31/24
On the pen
☆
☆
☆
☆
☆
“Dave is amazing. He works so hard get the the information to everyone.”
Hand1244 via Apple Podcasts ·
United States of America ·
10/18/24
Recent Episodes
Send us a textIn this episode of On The Pen: The Weekly Dose, host Dave Knapp dives into the latest updates in obesity medicine, with insightful takes on current treatment breakthroughs, new medication approvals, and tips on navigating healthcare options. This week’s deep dive also touches on...
Published 11/12/24
Send us a textSemaglutide News: https://www.onthepen.com/post/select-trial-update-semaglutide-s-cardiovascular-benefits-and-psychiatric-safety-profile-highlighteViking Therapeutics News:https://www.onthepen.com/post/vk2735-vikingtideAstraZeneca News:...
Published 11/05/24
Published 11/05/24
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
